5/8/2013 9:39:40 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IRVINE, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer, reported today that total revenues for the first quarter 2013, increased to $1.6 million, up 27% from the first quarter 2012. Revenues from the Company's core prenatal testing markets in the first quarter grew by 158% over the corresponding period in 2012. On a sequential basis, prenatal testing revenues in the 2013 first quarter grew by 21% over the 2012 fourth quarter, while total revenues grew 11% over the same period.
Help employers find you! Check out all the jobs and post your resume.
comments powered by